• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Zuclopenthixol

CAS No. 53772-83-1

Zuclopenthixol ( alpha-Clopenthixol | Clopenthixol | Zuclopenthixol )

产品货号. M18758 CAS No. 53772-83-1

Zuclopenthixol 是一种噻吨,其治疗作用与吩噻嗪类抗精神病药相似。它是 D1 和 D2 多巴胺受体的拮抗剂。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
25MG ¥243 有现货
50MG ¥316 有现货
100MG ¥446 有现货
200MG ¥648 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Zuclopenthixol
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Zuclopenthixol 是一种噻吨,其治疗作用与吩噻嗪类抗精神病药相似。它是 D1 和 D2 多巴胺受体的拮抗剂。
  • 产品描述
    Zuclopenthixol, also known as Cisordinol, Clopixol, Acuphase, zuclopentixol, is a typical antipsychotic drug of the thioxanthene class. It was introduced in 1962 by Lundbeck. Zuclopenthixol is the cis-isomer of clopenthixol. Zuclopenthixol is not approved for use in the United States. Zuclopenthixol has high affinity for both dopamine D1 and D2 receptors, for α1-adrenoceptors and 5-HT2 receptors but no affinity for cholinergic muscarine receptors. It has weak histamine (H1) receptor affinity and no α2-adrenoceptor blocking activity.(In Vivo):After acute treatment, Zuclopenthixol (0.2 and 0.4 mg/kg)-treated animals exhibit ethopharmacological profiles characterized by a decrease in offensive behaviors without impairment of motor activity (0.2 mg/kg). In contrast, the antiaggressive action of the highest dose used (0.4 mg/kg) is accompanied by a marked increase of immobility. After subchronic treatment, no tolerance to Zuclopenthixol antiaggressive or motor activity is observed.Administration of Zuclopenthixol (0.7 and 1.4 mg/kg) significantly elevate MDA level compared to respective controls. Nevertheless, there is no difference between the two dose levels with respect to their effect on rat brain MDA level. Post hoc pairwise comparisons between the means of groups (n=12) receiving different dose levels of Zuclopenthixol reveal that administration of 1.4 mg/kg of Zuclopenthixol significantly reduces GSH level compared to both vehicle-treated and Zuclopenthixol (0.7 mg/kg)-treated animals (P<0.001). Nevertheless, the lower dose of the drug does not affect rat brain GSH level. Animals receiving 0.7 or 1.4 mg/kg of Zuclopenthixol exhibits significantly higher GSH levels than SCO treated animals. Administration of 0.7 mg/kg of Zuclopenthixol significantly elevated GSHPx activity compared to vehicle treated animals.
  • 体外实验
    ——
  • 体内实验
    After acute treatment, Zuclopenthixol (0.2 and 0.4 mg/kg)-treated animals exhibit ethopharmacological profiles characterized by a decrease in offensive behaviors without impairment of motor activity (0.2 mg/kg). In contrast, the antiaggressive action of the highest dose used (0.4 mg/kg) is accompanied by a marked increase of immobility. After subchronic treatment, no tolerance to Zuclopenthixol antiaggressive or motor activity is observed. Administration of Zuclopenthixol (0.7 and 1.4 mg/kg) significantly elevate MDA level compared to respective controls. Nevertheless, there is no difference between the two dose levels with respect to their effect on rat brain MDA level. Post hoc pairwise comparisons between the means of groups (n=12) receiving different dose levels of Zuclopenthixol reveal that administration of 1.4 mg/kg of Zuclopenthixol significantly reduces GSH level compared to both vehicle-treated and Zuclopenthixol (0.7 mg/kg)-treated animals (P<0.001). Nevertheless, the lower dose of the drug does not affect rat brain GSH level. Animals receiving 0.7 or 1.4 mg/kg of Zuclopenthixol exhibits significantly higher GSH levels than SCO treated animals. Administration of 0.7 mg/kg of Zuclopenthixol significantly elevated GSHPx activity compared to vehicle treated animals.
  • 同义词
    alpha-Clopenthixol | Clopenthixol | Zuclopenthixol
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    D1| D2
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    53772-83-1
  • 分子量
    400.96
  • 分子式
    C22H25ClN2OS
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : ≥ 150 mg/mL; 374.10 mM
  • SMILES
    C1CN(CCN1CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl)CCO
  • 化学全称
    2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Khalifa AE: Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms. Pharmacol Biochem Behav. 2003 Jul;75(4):755-62.
产品手册
关联产品
  • Macrozamin

    Macrozamin 具有致癌、致突变、致畸和神经毒性特性。Macrozamin 是从苏铁植物中分离出来的天然产物。

  • PDEC-NB

    PDEC-NB 是一种用于抗体药物偶联物 (ADC) 的二硫键可裂解接头。

  • N-Boc-PEG5-bromide

    N-Boc-PEG5-bromide 是一种可裂解的 ADC 连接体,用于合成抗体药物偶联物 (ADC)。 N-Boc-PEG5-bromide 是一种基于 PEG 和烷基/醚的 PROTAC 连接体。